The UAE has announced a travel ban from January 10 for citizens of the UAE who are not vaccinated against Covid-19.
To travel, vaccinated citizens are required to obtain a booster dose according to the national booster dose protocol.
The announcement was made on Saturday by the Ministry of Foreign Affairs and International Cooperation (MoFAIC), in coordination with the National Crisis and Disaster Management Authority (NCEMA).
There are exceptions that will be made. Travel is permitted for unvaccinated citizens who are medically exempt from vaccination, humanitarian cases, as well as people traveling for medical and treatment purposes.
#NCEMA and @MoFAICUAE: Travel ban for citizens of the United Arab Emirates who have not been vaccinated with # Covid19 vaccine, from January 10, 2022, with the obligation to obtain the booster dose for fully vaccinated people. With an exemption for medically exempt vaccine, humanitarian and treatment cases pic.twitter.com/zUw1FoSLBt
– NCEMA WATER (@NCEMAUAE) January 1, 2022
The Department of Foreign Affairs and NCEMA have stressed the importance of ensuring that all travelers adhere to preventive measures, that travelers seek information on the status of the infection in selected travel destinations and communicate with UAE diplomatic missions in a foreign country where they are suspected of having been infected. .
On Saturday January 1, MoHAP noted that 36,384 doses of the Covid-19 vaccine had been administered in the previous 24 hours.
The total number of doses provided to date therefore stands at 22,679,877, with a vaccine distribution rate of 229.31 doses per 100 people.
At the end of December, the Ministry of Health approved the emergency use of Sinopharm’s new recombinant protein vaccine CNBG. The new vaccine will be produced and distributed by Hayat Biotech, a joint venture between G42 and Sinopharm CNBG. It will be available to the public as a booster dose from January 2022.
Read: UAE Approves New Sinopharm Vaccine For Use As Booster Injections
The Sinopharm protein vaccine uses proteins from the spinal cord that surround the Covid-19 virus. It allows the body to identify the virus and fight it off if exposed, which will help prevent several variants, according to the state news agency. WAM United Arab Emirates health sector spokesperson Dr Noura Al Ghaithi reported after the vaccine was approved.
“The Sinopharm protein vaccine and other Sinopharm vaccines are effective in producing antibodies. However, the new protein-based vaccine may achieve more comprehensive results to ensure greater efficacy in preventing variants, ”added Dr Noura.